…

Reference literature discusses Tirzepatide in the context of combined GIP and GLP-1 receptor research. INNMI supplies this product for laboratory research in the SKU and vial specifications listed below.
| Available specification | Abbreviation / SKU | |
|---|---|---|
| 5mg × 10 vials USD 64.77 | TR5 | |
| 10mg × 10 vials USD 93.92 | TR10 | |
| 15mg × 10 vials USD 116.59 | TR15 | |
| 20mg × 10 vials USD 152.34 | TR20 | |
| 30mg × 10 vials USD 204.03 | TR30 | |
| 40mg × 10 vials USD 240.03 | TR40 | |
| 50mg × 10 vials USD 281.76 | TR50 | |
| 60mg × 10 vials USD 349.77 | TR60 | |
| 80mg × 10 vials USD 472.84 | TR80 | |
| 100mg × 10 vials USD 531.14 | TR100 |
Public redacted reference reports from innmi.com, for the specifications shown. Request the matching document for the current batch.









